[211+ Pages Report] According to a market research study published by Facts and Factors, the demand analysis of Global Anticoagulants Market size & share revenue was valued at around USD 23,817.5 million in 2021 and is estimated to grow over USD 42,756.02 million by 2028, at a CAGR of approximately 9.01% between 2022 and 2028. The key market players are listed in the report with their sales, revenues and strategies are Aspen Holdings, Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company, Limited GlaxoSmithKline plc., johnson & johnson, janssen Pharmaceuticals, Inc., Portola Pharmaceuticals, Inc., Sanofi S.A., and Others.

NEW YORK, United States, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Facts and Factors has published a new research report titled “Anticoagulants Market Size, Share, Growth Analysis Report By Drug Class (NOACs, Heparin & LMWH, Vitamin K Antagonist, Others), By Route of Administration (Oral anticoagulant, Injectable anticoagulant), By Application (Atrial fibrillation & heart attack, Stroke, Deep vein embolism (PE), Others), and By Region - Global Industry Insights, Comparative Analysis, Trends, Statistical Research, Market Intelligence, and Forecast 2022 – 2028” in its research database.

“According to the latest research study, the demand of global Anticoagulants Market size & share in terms of revenue was worth of USD 23,817.5 million in 2021 and it is projected to exceed around USD 42,756.02 million mark by 2028, growing at a compound annual growth rate (CAGR) of approximately 9.01% during the forecast period 2022 to 2028.”

What is Anticoagulants? How big is the Anticoagulants Market?

Market Overview:

When blood thickens and forms a semi-solid mass in any part of the body, blood clots occur. This can lead to significant complications such as stroke, heart attack, pulmonary embolism, transient ischemic attack, and deep vein thrombosis (DVT). As a result, doctors all across the world are prescribing anticoagulant medicines to patients who are at high risk of clotting. These medications aid in blood thinning, preventing or lowering blood clotting, and extending clotting time.

Get a Free Sample PDF of this Research Report for more Insights with a Table of Content, Research Methodology, and Graphs - https://www.fnfresearch.com/sample/anticoagulants-market

(A free sample of this report is available upon request; please contact us for more information.)

Our Free Sample Report Consists of the Following:

• Introduction, Overview, and in-depth industry analysis are all included in the 2022 updated report.
• The COVID-19 Pandemic Outbreak Impact Analysis is included in the package
• About 211+ Pages Research Report (Including Recent Research)
• Provide detailed chapter-by-chapter guidance on Request
• Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2022
• Includes Tables and figures have been updated
• The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
• Facts and Factors research methodology

(Please note that the sample of this report has been modified to include the COVID-19 impact study prior to delivery.)

Report Scope

Report Attribute	Details
Market Size in 2021	USD 23,817.5 Million
Projected Market Size in 2028	USD 42,756.02 Million
CAGR Growth Rate	9.01% CAGR
Base Year	2021
Forecast Years	2022-2028
Key Market Players	Aspen Holdings, Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company, Limited GlaxoSmithKline plc., johnson & johnson, janssen Pharmaceuticals, Inc., Portola Pharmaceuticals, Inc., Sanofi S.A., and Others
Key Segment	By Drug Class, Route of Administration, Application, and Region
Major Regions Covered	North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
Purchase Options	Request customized purchase options to meet your research needs. Explore purchase options

Global Anticoagulants Market Dynamics

According to recent studies, hypercoagulability in those infected by the coronavirus illness (COVID-19) pandemic may be one of the major causes of death worldwide. As a result, the increasing number of cases is positively influencing the need for anticoagulant medications to treat thrombosis in critically ill or hospitalized patients. Additionally, risk factors such as prolonged sitting, smoking, trauma, blood disorders, and autoimmune diseases can cause blood clotting in various sections of the body. This, combined with the rising frequency of human immunodeficiency virus (HIV), hepatitis C, Lyme disease, obesity, cancer, and chronic inflammation, is another key driver bolstering market expansion. Aside from that, the world's aging population is causing an increase in demand for surgical services. Surgery frequently necessitates prolonged bed rest, which raises the risk of blood clotting and the overall sales of anticoagulant medicines.

Furthermore, rising diagnosis rates and rising demand for target therapies are propelling the industry forward. The rise of internet pharmacies is also fuelling the global demand for anticoagulant medications. However, the worldwide anticoagulants market is hampered by rigorous regulations imposed by various governments. Furthermore, the danger of side effects and difficulties connected with the use of oral anticoagulants impedes the global anticoagulants market's growth.

Browse the full “Anticoagulants Market Size, Share, Growth Analysis Report By Drug Class (NOACs, Heparin & LMWH, Vitamin K Antagonist, Others), By Route of Administration (Oral anticoagulant, Injectable anticoagulant), By Application (Atrial fibrillation & heart attack, Stroke, Deep vein embolism (PE), Others), and By Region - Global Industry Insights, Comparative Analysis, Trends, Statistical Research, Market Intelligence, and Forecast 2022 – 2028” Report at https://www.fnfresearch.com/anticoagulants-market

Anticoagulants Market: COVID-19 Impact Analysis

Due to the rapid pace of research, COVID-19 infection is predicted to have a significant impact on the anticoagulant business. According to a study published in the American Journal of Cardiovascular Drugs in 2020, more than ten clinical trials are currently underway to assess the potential of anticoagulants in COVID-19 patients, and research on parenteral administration strategies for these drugs is being conducted for use in critically ill COVID-19 patients. As a result, the COVID-19 pandemic is projected to have both direct and indirect effects on the market.

Major anticoagulant companies are focusing on launching clinical trials of anticoagulant drugs to reduce the risk of COVID-19-related blood clotting in adults. Over the pandemic period, almost every industry in the world has suffered a setback. This is owing to significant interruptions in their respective production and supply-chain activities caused by multiple precautionary lockdowns and other restrictions imposed by governing bodies throughout the world.

Anticoagulants Market: Segmentation Analysis

The global Anticoagulants market is segregated based on Drug Class, Route Of Administration, and Application.

In terms of Drug Class, the NOACs category is currently a prominent revenue-generating segment in the anticoagulants market and is expected to dominate over the forecast period, owing to expanding NOAC adoption in developing countries and rising use of NOACs over warfarin. NOACs medications are available on market, including rivaroxaban, betrixaban, apixaban, edoxaban, and dabigatran. Furthermore, NOACs have several advantages over warfarin, including a faster onset of action, less drug and food interaction, predictable pharmacokinetic activity, a shorter half-life, and no dietary restrictions. These have contributed to the market's expansion.

In terms of Application, the atrial fibrillation & heart attack category is currently a key revenue generator and is expected to remain dominant over the projected period because of the vast target population and rising use of anticoagulants in the treatment of these disorders. However, DVT is predicted to be the fastest-growing market segment, owing to increased DVT prevalence and technical advancements in DVT diagnostics.

Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/anticoagulants-market

Competitive Landscape

Some of the main competitors dominating the global Anticoagulants market include - 

• Aspen Holdings
• Bayer AG
• Boehringer Ingelheim GmbH
• Bristol-Myers Squibb Company
• Daiichi Sankyo Company
• Limited GlaxoSmithKline plc.
• johnson & johnson
• janssen Pharmaceuticals, Inc.
• Portola Pharmaceuticals, Inc.
• Sanofi S.A.

Key Insights from Primary Research:

• As per the analysis shared by our research analyst, the Anticoagulants market is estimated to grow annually at a CAGR of around 9.01% over the forecast period (2022-2028).
• In Terms Of Revenue, The Anticoagulants market size was valued at around USD 23,817.5 million in 2021 and is projected to reach USD 42,756.02 million by 2028. Due to a variety of driving factors, the market is predicted to rise at a significant rate.
• In terms of Route of Administration, oral anticoagulants are expected to earn the most market revenue.
• In terms of Drug Class, the NOACs category is now a key revenue-generating area in the anticoagulants market and is likely to dominate during the projection period because of increased NOAC adoption in developing countries and rising usage of NOACs over warfarin.
• On the basis of region, the “North America” is likely to lead the worldwide market throughout the projected period.

Have Any Query? Ask Our Experts: https://www.fnfresearch.com/inquiry/anticoagulants-market

Key questions answered in this report:

• What is the market size and growth rate forecast for Anticoagulants industry?
• What are the main driving factors propelling the Anticoagulants Market forward?
• What are the leading companies in the Anticoagulants Industry?
• What segments does the Anticoagulants Market cover?
• How can I receive a free copy of the Anticoagulants Market sample report and company profiles?

Regional Dominance:

North America accounted for almost half of the global market in the forecast period and is likely to maintain its dominance during the forecast period. This was ascribed to increased demand for novel therapies, the presence of major stakeholders, early diagnosis, enhanced healthcare infrastructure, the presence of qualified medical experts, and a larger target population. Due to growing knowledge about the therapeutic benefits of anticoagulants in disease management and the country's expanding obesity incidence, the United States accounted for the largest proportion of anticoagulants in the region. Furthermore, it has the world's highest obesity rate. Thus driving the regional market.

The Asia-Pacific area, on the other hand, is predicted to grow at the fastest rate during the projection period, owing mostly to improved healthcare infrastructure in developing nations, higher diagnosis rates, increased health awareness, and rising prevalence of cardiovascular disease and VTE. Furthermore, continuing economic development, such as the expansion of healthcare infrastructure and the improvement of healthcare awareness, has aided market growth.

Request for Customization on this Report as per your requirements - https://www.fnfresearch.com/customization/anticoagulants-market

(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)

The global Anticoagulants market is segmented as follows:

By Drug Class

• NOACs
• Heparin & LMWH
• Vitamin K Antagonist
• Others

By Route of Administration

• Oral anticoagulant
• Injectable anticoagulant

By Application

• Atrial fibrillation & heart attack
• Stroke
• Deep vein embolism (PE)
• Others

By Region

• North America
  • U.S.
  • Canada
  • Rest of North America
• Europe
  • France
  • UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

Ask For Free Sample Report of the Global Anticoagulants Market @ https://www.fnfresearch.com/sample/anticoagulants-market

Key Offerings:

• Market Size & Forecast by Revenue | 2022−2028
• Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities
• Market Segmentation – A detailed analysis by Drug Class, Route of Administration, Application, and Geography
• Competitive Landscape – Top Key Vendors and Other Prominent Vendors

Browse Other Related Research Reports from Facts & Factors:

• Cardiac Rhythm Management Devices Market: https://www.fnfresearch.com/cardiac-rhythm-management-devices-market
  
• Electroencephalography Equipment Market: https://www.fnfresearch.com/electroencephalography-equipment-market
  
• Breast Biopsy Market: https://www.fnfresearch.com/breast-biopsy-market
  
• In Vitro Fertilization (IVF) Market: https://www.fnfresearch.com/in-vitro-fertilization-market
  
• Healthcare CRM Market: https://www.fnfresearch.com/healthcare-crm-market
  
• Radiopharmaceutical Market: https://www.fnfresearch.com/radiopharmaceutical-market
  

About Facts & Factors:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.

Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Follow Us on LinkedIn: https://www.linkedin.com/company/fnfresearch

Follow Us on Twitter: https://twitter.com/fnfresearch

Follow Us on Facebook: https://www.facebook.com/factsandfactors/

Contact Us:

Sanu Thomas

USA: +1 347 690-0211

United Kingdom: +44 2032 894158

Japan: +81 50 5806 9039

India: +91 96043 17127

Email: sales@fnfresearch.com

Web: https://www.fnfresearch.com

Blog: http://fnfnewsblog.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.